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certainly bring fewer hassles in relation to philosophical
questions about animal rights or the moral equivalence
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Answer
Dear Dr. Hélcio Giffhorn,
Initially, we would like to thank you for your letter
regarding the article “Trends in animal experimentation”,
published in issue 24.4 of the Brazilian Journal of
Cardiovascular Surgery (BJCVS) [1]. We believe that this is
an additional opportunity to comment on other aspects
related to animal experimentation.
Some years ago, in the Instructions to Authors of BJCVS,
ethics in animal experimentation has been receiving special
attention. On the item Research with Humans and Animals
is established that “In experimental studies involving
animals, the standards established in the Guide for the
Care and Use of Laboratory Animals (Institute of
Laboratory Animal Resources, National Academy of
Sciences, Washington, DC, 1996) and the Ethical principles
for animal experimentation of the Brazilian College of Animal
Experimentation (COBEA) must be respected, in accordance
with the guidelines of the International Committee of
Medical Journal Editors - Vancouver Group. Moreover,
in Instructions to Authors, is established that in the
Methods section of the study must state that “the research
was approved by the Research Ethics Committee of its
institution”.
Ethical aspects in performing the articles published in
BJCVS have being contemplated, including the form of
evaluation of manuscripts submitted for publication in
BJCVS, in which members of the Editorial Board should
determine whether these aspects were contemplated both
in studies involving patients – which includes good clinical
practices, approval by the Scientific and Ethics Committees,
obtaining Written Informed Consent - but also in research
using animals, with emphasis on proper management of
them.
Finally, we believe that knowledge of physiology and
needs of each animal species is essential to ensure not
only the reliability of results obtained in the research, but
mainly to avoid inadequate handling of animals and the
consequent suffering and unnecessary stress.
Sincerely,
Rosangela Monteiro, Ricardo Brandau, Walter J.
Gomes, Domingo M. Braile
REFERENCE
  
1. Monteiro R, Brandau R, Gomes WJ, Braile DM. Tendências
em experimentação animal. Rev Bras Cir Cardiovasc.
2009;24(4):506-13.
ROOBY study: A critical view
In a recent article published in The New England Journal
of Medicine (NEJM), Shroyer et al. [1], in their study ROOBY
Trial, present outcomes quite controversial of coronary
surgery when compared to techniques already well
established currently, such as coronary artery bypass
grafting (CABG) with and without cardiopulmonary bypass
(CPB).
The ROOBY study was performed at Veterans Hospitals
of the United States of America, against several other
previously published studies [2,3], which showed benefit
of off-pump CABG surgery over the on-pump technique,
in several outcomes in specific subgroups such as elderly
and patients with serious coexisting morbidities.
Some comments should be made about the “ROOBY
TRIAL”:
1. The study is not double-blind: the surgeon knew
which technique would be employed. As the criteria for
complete and incomplete revascularization was based on
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the number of grafts planned before the operation and the
number of grafts really confectioned for each patient, it
was enough that the surgeon of the off-pump group
overestimated the indication of grafts so that there was a
negative influence on the secondary endpoint of the CABG
group. After all, it is technically more difficult to make grafts
to multiple territories in the same beating heart procedure,
compared with the procedure with the heart stopped.
2. The surgeon, to participate in the study, had to prove
that previously performed only 20 off-pump CABG surgeries
(the experience average was 50 cases). Among these 20
cases, the surgeon should present as evidence, only a few
cases he had performed as off-pump CABG in any territory
of the heart. This fact will influence the endpoint that
analyzes complete myocardial revascularization, which will
impair off-pump CABG, in which the technical difficulty is
greater, requiring a higher learning curve especially in triple-
artery patients (representing 66.1% of the population of
the study). Therefore, 20 cases of experience does not seem
sufficient for the surgeon is considered allocated on the
learning curve plateau of off-pump CABG. On the other
hand, are 50 cases, by coincidence, sufficient?
3. More than half of the procedures in both groups were
performed by resident physicians. It is obviously that this
fact does not deserve too much comments as their positions
in the learning curve. This impaired the outcomes of the
ROOBY Trial. It impaired mainly the off-pump CABG group,
in which the technical difficulty is greater.
4. The study was composed of more than 99% of male
patients, which was not possible to extrapolate the results
for women.
5. There was cross-over three times higher in the off-
pump CABG group, or that is,  there was a higher conversion
of procedure intraoperatively in this group. This difference
also represented statistical significance. Despite the cross-
over, patients who were converted from one procedure to
another continued being evaluated as originally planned.
This means that patients randomized to the off-pump CABG
group who underwent surgery using CPB (by conversion)
had all their complications and negative outcomes
computed in the off-pump CABG group, when they should
have been evaluated as participants of the on-pump CABG
group.
6. In the analysis of the grafts patency, through
catheterization, it was not performed follow-up of 35.6% of
patients. So we do not know how it would be a real
comparison of outcomes compared to the initial group. This
implies that the risk analysis of loss of permeability should
have been examined in the light of an analysis of clinical
pre-trial characteristics only of the group analyzed in terms
of arterial patency (or that is, those who performed
catheterization). With this, a new comparative analysis of
pre-intervention clinical characteristics should have been
performed (identifying possible differences between on-
pump and off-pump CABG groups only from patients who
have undergone catheterization, making statistical analysis
using logistic regression, with removal of the influence of
risk factors for loss of patency if there were significant
differences (diabetes, hypertension, smoking, etc.). This
was not peformed in the study, since the authors took into
account the clinical characteristics of the initial total
(without loss of 35.6% for assessment by catheterization),
in which there were no significant differences between
groups, which mistakenly led to non-compliance of the need
for further analysis of pre-intervention clinical
characteristics, and subsequent analysis with logistic
regression.
7. The population evaluated with cardiac catheterization
accounted for only 64.4% of the total population of the
randomization. One hundred and twelve (8.1%) patients
received radial artery grafts - not specified to which
territories; sixty (4.3%) had used left mammary to territory
different from the anterior descending. The study does not
specify which groups received these grafts and in which
percentage. Any differences in the concentration of these
grafts in one of the groups influence the outcomes. These
percentages influence the patency and certainly in mortality
from cardiac causes. And in this data are only counted
patients who were evaluated by cardiac catheterization. As
for the remaining who did not undergo catheterization
(35.6%), it is not mentioned in the study the pattern of graft
used. Again, this part that is not approached in the study
certainly influences the outcomes negatively or positively
to one of the groups, or also the possibility of influence nil.
This is a gap that the study misses.
8. Regarding neurocognitive assessment, similar
phenomenon occurred to the evaluation of graft patency,
and less than half of the patients was assessed from this
point of view. Or that is, once again there was the mistake
of not evaluating the patients in light of the pre-intervention
clinical characteristics that affect the outcomes. The
patients were assessed as if they were homogeneous
groups, when in fact we do not have this information,
because this comparison of the groups that were really
assessed (only those who underwent follow-up of the the
secondary outcome in question - neurocognitive function)
was not performed.
9. It was demonstrated higher mortality in the off-pump
CABG group. This probably was the result of two aspects:
a) lower graft patency in the off-pump CABG group and b)
increased number of incomplete revascularization in the
off-pump CABG group. Both aspects are influenced directly
by the surgeons skill. Clearly, in this study the ability of
surgeons who operated in the off-pump CABG group was
not in scale worthy of trust, considering that the average
of off-pump procedures was of only 50 procedures
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performed. The same may be applicable to the on-pump
CABG group, however, we must not forget that the technical
difficulty of making a bypass without CPB is higher
compared to on-pump, especially for surgeons who have
not reached the plateau in the learning curve.
10. CABG is itself a procedure that demands a lot of
technical skill. The key to success of this surgery is graft
patency. Confirmation of graft patency before and after
protamine administration requires an objective
documentation, using available technologies, such as
Flowmeter [4]. Subjective evaluations, such as digital
palpation, normal electrocardiogram or hemodynamic
stability are unreal. The graft can already be performed
occluded during the closure of the chest. Accordingly,
coronary angiography performed as follow-up shows
occlusion of the graft, which could be attributed to
technical failure during the closure of the chest, rather than
poor rate of graft patency related to a technique or another.
In this study, Shroyer et al. [1] have not reported the need
to objectively verify the graft patency after the procedure.
In our view, this is the biggest flaw of this study, which
invalidates the results and conclusions. CABG without CPB
may be more difficult technically than surgery with CPB,
however, when comparing results of grafts patency, the
starting point is its determination prior to closure of the
chest, which should be the same in both techniques. If
different, it indicates that the surgeon is inexperienced with
either technique.
Finally, we expect the ROOBY study, published in a
journal of high global impact (NEJM), is read and interpreted
in the light of reality and faults committed by their authors.
Also, we expect that such study does not impair the use of
a surgical procedure as important as the off-pump CABG
surgery and thus hindering its use and benefits to our
patients.
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Cystatin C and Glomerular Filtration Rate
Dear Editor,
I have read the recent publication by Felicio et al.
(RBCCV/BJCVS 24.3) with a great interest. Felicio et al. [1]
reported on the comparative usage of “Cystatin C and
glomerular filtration rate in the cardiac surgery with
cardiopulmonary bypass”. Felicio et al. [1] concluded that
“The cystatin C and the Cys-GFR showed significant
changes after cardiac surgery when compared with the
creatinine and respective GFR calculated by the Cockcroft-
Gault and MDRD formulas”. Indeed, the use of cystatin C is
accepted in cardiac surgery [2,3]. However, there is a
considerable concern on cost of cystatin C. Momeni et al.
[3] noted that “In patients with normal preoperative renal
function undergoing coronary artery bypass graft, measured
creatinine concentration remains a cheap and easy way of
estimating renal function.” It will be a good information if
Felicio et al. could provide more data on the comparative
cost effectiveness of the studied alternative approaches.
Professor Viroj Wiwanitkit – Bangkok/Thailand
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